Dr. Henry Miller Quoted in Reuters Vaccine Article

Title: How drugmakers can keep their pledge and still deliver an October vaccine surprise
By: Michael Erman, Julie Steenhuysen, Reuters

As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available to prove one is safe and effective in that time frame. . .

. . .

Dr. Henry Miller, a senior fellow at the Pacific Research Institute think tank and former director of the FDA’s office of biotechnology, said an emergency use authorization based on a small number of infections would not deliver an adequate answer on the safety of a vaccine intended for use by millions of healthy people. Some side effects could take four to six months to occur, he said. . .

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Subscribe to our newsletter:

This field is for validation purposes and should be left unchanged.
Scroll to Top